Connect with us

Hi, what are you looking for?

News

Wave Life Sciences: Excellent Early Data, Major Collaborations, Needs Cash (NASDAQ:WVE)

Wave Life Sciences Ltd. (NASDAQ:WVE) develops stereopure oligonucleotides using its PRISM platform to target disease-causing genetic mutations. This is its pipeline:

Lead assets are WVE-N531 targeting exon 53 skipping DMD, and

Read the full article here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Videos

Watch full video on YouTube

Videos

Watch full video on YouTube

Videos

Watch full video on YouTube

Videos

Watch full video on YouTube